Treatment With Pazopanib for Neoadjuvant Breast Cancer

NCT00849472 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Breast

Interventions

DRUG: doxorubicin + cyclophosphamide
DRUG: paclitaxel + pazopanib
PROCEDURE: surgery
DRUG: pazopanib monotherapy

Sponsor

GlaxoSmithKline

Collaborators

[object Object]